Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 112   

Articles published

JNJ 99.58 -0.21 (-0.21%)
price chart
First-Quarter Profit Falls at Johnson & Johnson
First-quarter profit for Johnson & Johnson, the world's biggest maker of health care products, uncharacteristically fell 8.6 percent, to $4.32 billion, hurt by sharply unfavorable exchange rates, a major divestiture and competition to its new hepatitis ...
Johnson & Johnson's Earnings: The Good, The Bad and The Ugly
To gain some insight into this top healthcare stock's weakness so far in 2015, let's dig into the company's first-quarter earnings, released earlier this week.
3 Long-Tail Growth Drivers for Johnson & Johnson
Johnson & Johnson isn't your traditional pharmaceutical company -- it's actually a healthcare conglomerate comprised of a consumer healthcare products division, a global medical devices segment, and of course its gigantic pharmaceutical segment.
Johnson & Johnson Reveals Plans To Expand Into Asia  Bidness ETC
Johnson & Johnson (NYSE:JNJ) To Expand In Asia  USMarketsDaily (blog)
Johnson & Johnson May See EPS Drag Through 2018
Late last week, a California court judge issued a ruling in the biosimilar Neupogen case between Amgen and Sandoz that could have implications for Johnson & Johnson and its biosimilar Remicade case versus Celltrion. The ruling addressed two specific ...
BRIEF-Genmab reach $10 mln milestone in Johnson & Johnson collaboration
April 16 (Reuters) - Genmab. * Says achieves 10 million dollar milestone in daratumumab collaboration with Janssen, a pharmaceutical company of Johnson & Johnson. * Says has reached fifth milestone in its daratumumab collaboration with Janssen.
Johnson & Johnson is still getting whacked by the strong dollar
On Tuesday morning, the pharmaceutical giant reported first quarter earnings per share of $1.56, beating estimates of $1.53, on revenues of $17.4 billion, more than the $17.32 billion forecast.
Johnson & Johnson Still Attractive Despite Strong Dollar
Yet the company's diversified operations, which include over-the-counter drugs such as Tylenol and the allergy brand Zyrtec and its medical devices businesses, are one of the company's biggest assets.
Ignore The Earnings Results And Include Johnson & Johnson In Your ...  Seeking Alpha
Stocks to Watch: JP Morgan, Wells Fargo, Johnson & Johnson
Wells Fargo reported its first-quarter profit fell 1.5% as the nation's fourth-largest bank by assets continued to face pressure on its lending margins.
Google and Johnson & Johnson Join Forces to Improve Robo-Surgery
Last week, Johnson & Johnson announced the kickoff of a collaboration between its Ethicon division and Google's Life Sciences team, a pairing that seeks to innovate robotic surgical technology in the near future.
Google robots for the operating theatre  Mail & Guardian Online
Johnson & Johnson, Pfizer and Zimmer Holdings are Top Stock Picks
They maintain attractive payout ratios, with Johnson & Johnson yielding roughly 2.8% and Pfizer paying a 3.2% dividend yield.